Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
To determine (i) correlates for etanercept (ETA) discontinuation after achieving an inactive disease and for the subsequent risk of flare and (ii) to analyze the effectiveness of ETA in the re-treatment after a disease flare. Data from two ongoing prospective registries, BiKeR and JuMBO, were used f...
Saved in:
Published in | Arthritis research & therapy Vol. 23; no. 1; p. 118 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
16.04.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!